a phase i/ii trial of seclidemstat in combination with azacitidine for patients with mds and cmml
Published 1 month ago • 39 plays • Length 1:37Download video MP4
Download video MP3
Similar videos
-
1:33
phase i trial results for oral azacitidine and venetoclax in r/r aml
-
1:35
phase i study of plx51107, a novel bet inhibitor, in combination with azacitidine in r/r mds and aml
-
1:59
phase i study of pevonedistat, azacitidine, and venetoclax in patients with r/r aml
-
2:39
a phase ii trial of ruxolitinib and azacitidine combination therapy in patients with myelofibrosis
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
17:06
preoperative evaluation cataract surgery
-
8:24
how to use the cryocheck™ factor viii inhibitor kit
-
43:10
venetoclax plus gilteritinib for flt3-mutated relapsed/refractory acute myeloid leukemia
-
3:20
safety run-in of a phase ii trial of cpx-351 plus pomalidomide in aml with mds-related changes
-
1:30
a phase i trial of voruciclib /- venetoclax for the treatment of nhl and aml
-
1:25
phase ii trial of eprenetapopt plus azacitidine: long-term follow up
-
1:04
clad-ldac-ven induction therapy in aml: insights from a phase ii trial
-
1:37
a phase ii trial evaluating e7820 in patients with aml with splicing factor mutations
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
5:20
phase ib/ii study of nivolumab in combination with azacytidine ...
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
1:54
fusion-aml-001: molecular changes associated with azacitidine & durvalumab in tp53m aml and hr-mds
-
2:17
ventograft trial: aza, ven, and dli in patients with mds and aml who have relapsed following allosct
-
3:21
a phase i trial of hu8f4, an anti-pr1/hla-a2 monoclonal antibody, in r/r myeloid malignancies
-
2:58
long-term follow-up: phase ii study of apr-246 aza in tp53-mutated mds & aml
-
3:40
phase ii study of venetoclax and azacitidine vs induction chemotherapy in fit patients with aml